MDxHealth (MDXH) Cost of Revenue (2021 - 2026)

MDxHealth (MDXH) has 6 years of Cost of Revenue data on file, last reported at $10.8 million in Q1 2026.

• Quarterly Cost of Revenue rose 22.58% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.2 million (up 11.97% YoY) and the FY2025 annual result came in at $38.2 million, up 9.55% from the prior year.
• Cost of Revenue retreated to $10.8 million in Q1 2026 per MDXH's latest filing, from $10.9 million in the prior quarter.
• The five-year high for Cost of Revenue was $10.9 million in Q4 2025, with the low at -$3.3 million in Q2 2022.
• Average Cost of Revenue over 5 years is $7.1 million, with a median of $7.8 million recorded in 2024.
• Year-over-year, Cost of Revenue jumped 307.48% in 2023 and grew 1.86% in 2025.
• MDxHealth's Cost of Revenue stood at $5.7 million in 2022, then increased by 18.7% to $6.7 million in 2023, then soared by 37.09% to $9.2 million in 2024, then increased by 17.74% to $10.9 million in 2025, then dropped by 0.79% to $10.8 million in 2026.
• Business Quant data shows MDXH's Cost of Revenue at $10.8 million in Q1 2026, $10.9 million in Q4 2025, and $9.6 million in Q3 2025.